share_log

AN2 Therapeutics Q4 EPS $(0.57) Beats $(0.76) Estimate

Moomoo 24/7 ·  Mar 28 16:49

AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.76) by 25 percent. This is a 6.56 percent increase over losses of $(0.61) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment